Coeptis Therapeutics (COEP) Stock Chart & Stock Price History → How Biden has already won 2024 (From Porter & Company) (Ad) Free COEP Stock Alerts $0.36 -0.01 (-3.85%) (As of 03:40 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Coeptis Therapeutics Stock Price Performance5 Day Performance+5.56%1 Month Performance-2.31%3 Month Performance-23.85%6 Month Performance-63.11%Year-To-Date Performance-51.52%1 Year Performance-75.32% Receive COEP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. COEP Stock Chart for Thursday, May, 9, 2024 COEP Chart by TradingView Coeptis Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$0.38$0.38+1.33%$0.39$0.3779,187 shs$13.71 million05/07/2024$0.36$0.38+4.17%$0.42$0.35183,289 shs$13.53 million05/06/2024$0.36$0.36$0.38$0.3626,797 shs$12.99 million05/03/2024$0.37$0.36-2.60%$0.41$0.36316,082 shs$12.99 million05/02/2024$0.34$0.37+8.77%$0.38$0.33377,365 shs$13.34 million05/01/2024$0.31$0.34+9.12%$0.34$0.3279,866 shs$12.26 million Get the Latest News and Ratings for COEP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$0.33$0.31-7.02%$0.32$0.31202,006 shs$11.24 million04/29/2024$0.33$0.33+0.03%$0.34$0.3293,836 shs$12.09 million04/26/2024$0.32$0.33+3.98%$0.35$0.3252,491 shs$12.08 million04/25/2024$0.33$0.32-1.53%$0.34$0.3269,033 shs$11.62 million04/24/2024$0.34$0.33-2.39%$0.35$0.32148,061 shs$11.80 million04/23/2024$0.35$0.34-3.18%$0.35$0.3351,060 shs$12.09 million04/22/2024$0.33$0.35+4.53%$0.38$0.3288,989 shs$12.49 million04/19/2024$0.35$0.33-6.71%$0.38$0.32188,390 shs$11.95 million04/18/2024$0.37$0.35-3.19%$0.37$0.3550,856 shs$12.81 million04/17/2024$0.37$0.37+0.30%$0.38$0.3681,002 shs$13.23 million04/16/2024$0.37$0.37-0.57%$0.39$0.3576,665 shs$13.19 million04/15/2024$0.42$0.37-12.21%$0.43$0.33415,911 shs$13.26 million04/12/2024$0.43$0.42-3.14%$0.43$0.40234,947 shs$15.02 million04/11/2024$0.39$0.43+10.15%$0.48$0.401.60 million shs$15.50 million04/10/2024$0.39$0.39+0.26%$0.39$0.37138,928 shs$14.08 million04/09/2024$0.35$0.39+11.11%$0.41$0.36307,385 shs$14.04 million04/08/2024$0.32$0.35+8.29%$0.37$0.32524,426 shs$12.64 million04/05/2024$0.33$0.32-1.91%$0.34$0.31134,858 shs$11.67 million04/04/2024$0.31$0.33+4.77%$0.33$0.32145,584 shs$11.90 million04/03/2024$0.31$0.31-0.03%$0.33$0.31226,367 shs$11.35 million04/02/2024$0.30$0.31+6.68%$0.36$0.30931,734 shs$11.36 million04/01/2024$0.30$0.30-0.81%$0.32$0.29135,830 shs$10.65 million03/29/2024$0.30$0.30$0.30$0.29159,881 shs$10.73 million03/28/2024$0.30$0.30+0.13%$0.30$0.29157,269 shs$10.14 million03/27/2024$0.30$0.30-1.00%$0.31$0.29102,358 shs$10.13 million03/26/2024$0.31$0.30-2.44%$0.31$0.29121,535 shs$10.23 million03/25/2024$0.31$0.31-2.07%$0.33$0.30180,435 shs$10.49 million03/22/2024$0.32$0.31-0.63%$0.33$0.30167,708 shs$10.71 million03/21/2024$0.32$0.32-2.47%$0.34$0.31264,263 shs$10.78 million03/20/2024$0.31$0.32+5.47%$0.33$0.30222,602 shs$11.05 million03/19/2024$0.32$0.31-4.54%$0.36$0.31206,934 shs$10.48 million03/18/2024$0.36$0.32-10.44%$0.38$0.32274,645 shs$10.98 million03/15/2024$0.37$0.36-3.93%$0.39$0.35166,498 shs$12.26 million03/14/2024$0.39$0.37-4.10%$0.42$0.3671,151 shs$12.76 millionElon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.03/13/2024$0.43$0.39-8.24%$0.43$0.38148,398 shs$13.30 million03/12/2024$0.44$0.43-2.52%$0.45$0.4176,472 shs$14.50 million03/11/2024$0.48$0.44-9.17%$0.48$0.43189,998 shs$14.87 million03/08/2024$0.50$0.48-3.85%$0.50$0.47101,606 shs$16.37 million03/07/2024$0.54$0.50-7.38%$0.54$0.48137,493 shs$17.03 million03/06/2024$0.53$0.54+1.32%$0.56$0.51115,508 shs$18.39 million03/05/2024$0.54$0.53-1.30%$0.56$0.50159,064 shs$18.15 million03/04/2024$0.54$0.54-0.37%$0.55$0.52143,249 shs$18.39 million03/01/2024$0.58$0.54-6.71%$0.59$0.52412,328 shs$18.45 million02/29/2024$0.55$0.58+6.38%$0.68$0.561.82 million shs$19.78 million02/28/2024$0.49$0.55+11.79%$0.56$0.46373,740 shs$18.59 million02/27/2024$0.54$0.49-9.70%$0.55$0.46275,546 shs$16.63 million02/26/2024$0.49$0.54+9.89%$0.58$0.511.16 million shs$18.42 million02/23/2024$0.49$0.49+0.08%$0.52$0.47181,073 shs$16.76 million02/22/2024$0.49$0.49+0.74%$0.52$0.43427,036 shs$16.75 million02/21/2024$0.53$0.49-8.21%$0.56$0.47168,096 shs$16.63 million02/20/2024$0.50$0.53+6.41%$0.54$0.47286,273 shs$18.11 million02/19/2024$0.50$0.50$0.52$0.40349,500 shs$17.02 million02/16/2024$0.42$0.50+20.24%$0.52$0.40347,273 shs$17.02 million02/15/2024$0.33$0.42+25.76%$0.46$0.36501,142 shs$14.16 million02/14/2024$0.42$0.33-21.99%$0.41$0.33362,016 shs$11.26 million02/13/2024$0.45$0.42-6.02%$0.46$0.4272,965 shs$14.43 million02/12/2024$0.50$0.45-9.80%$0.50$0.45142,009 shs$15.35 million02/09/2024$0.48$0.50+3.92%$0.53$0.4890,229 shs$17.02 million02/08/2024$0.54$0.48-10.99%$0.55$0.48185,445 shs$16.38 million Related Companies: Chromocell Therapeutics Stock Price Chart Genetic Technologies Stock Price Chart BioCardia Stock Price Chart Tevogen Bio Stock Price Chart Organovo Stock Price Chart Sorrento Therapeutics Stock Price Chart Inhibikase Therapeutics Stock Price Chart PharmaCyte Biotech Stock Price Chart NanoString Technologies Stock Price Chart Senti Biosciences Stock Price Chart Receive COEP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:COEP) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.